The Chief Executive of US based biotechnology giant Moderna, Stephane Bancel, said that the company will charge governments between Rs 1855 and Rs 2755 per dose of its COVID-19 vaccine candidate. He further added that the price of the coronavirus vaccine will depend on the amount of doses ordered by the governments.
A senior EU official who is involved in the talks said that the European Commission wanted to reach a deal with Moderna for the supply of millions of doses of its vaccine candidate for a price below $25 per dose.
“Nothing is signed yet, but we`re close to a deal with the EU Commission. We want to deliver to Europe and are in constructive talks,” Bancel said, adding that a contract would be signed soon.
On November 16, US-based company Moderna announced that its COVID-19 vaccine has shown to be 94.5 % effective in preventing the deadly disease, giving a ray of hope to a world ravaged by the pandemic.
“This is a pivotal moment in the development of our COVID-19 vaccine candidate. Since early January, we have chased this virus with the intent to protect as many people around the world as possible. All along, we have known that each day matters,” said Stephane Bancel, CEO of Moderna.
“This positive interim analysis from our Phase 3 study has given us the first clinical validation that our vaccine can prevent COVID-19 disease, including severe disease,” Bancel said.
